logo-loader
viewBriacell Therapeutics Corp.

BriaCell Therapeutics CEO talks through Incyte collaboration and future plans in 2020

BriaCell Therapeutics Corp (CVE:BCT) (OTCMKTS:BCTXF) CEO Dr William Willams chatted with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The West Vancouver, British Columbia-based immuno-oncology-focused biotechnology company is developing the first off-the-shelf personalized immunotherapy targeting advanced breast cancer.

Quick facts: Briacell Therapeutics Corp.

Price: 10.8 CAD

TSX-V:BCT
Market: TSX-V
Market Cap: $7.8 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Mota Ventures sees strong sales increase amid COVID-10 Crisis

Mota Ventures (CSE: MOTA-OTCMKTS: PEMTF) CEO Ryan Hoggan joined Steve Darling from Proactive Vancouver to discuss how the company is doing during the Corona Virus crisis and how it has affected sales. Hoggan also told Proactive about a new product line the company has started and how excited...

52 minutes ago

2 min read